Convatec Group PLC (FRA:2CVU)

Market Cap	5.06B -7.4%
Revenue (ttm)	2.08B +6.6%
Net Income	149.05M -8.4%
EPS	0.07 -7.5%
Shares Out	n/a
PE Ratio	33.96
Forward PE	14.81
Dividend	0.20 (1.83%)
Ex-Dividend Date	Apr 17, 2026

Volume	n/a
Average Volume	n/a
Open	10.60
Previous Close	10.70
Day's Range	10.60 - 10.60
52-Week Range	9.95 - 13.90
Beta	n/a
RSI	49.64
Earnings Date	Aug 4, 2026

About Convatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorect...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1978
• Employees: 10,910
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2CVU

Financial Performance

In 2025, Convatec Group's revenue was $2.44 billion, an increase of 6.55% compared to the previous year's $2.29 billion. Earnings were $175.00 million, a decrease of -8.38%.

Financial numbers in USD